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cutoff score for the PCL-5. Two non-clinical samples were available: individuals who had experienced a 
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Abstract 
Previous research on the PTSD Checklist-5 (PCL-5) (Weathers et al., 2013) does not 
include non-clinical normative data; therefore, clinicians are unable to utilize the recommended 
Cutoff C calculation (Jacobson & Truax, 1991) to calculate a clinical cutoff score for their 
clients’ PCL-5 scores.  Further, previous research on the PCL-5 recommends values to determine 
clinical change; however, the recommended values are not calculated using a Reliable Change 
Index (RCI).  The purpose of this study was to collect data from a non-clinical population to aid 
in the process of determining a RCI and clinical cutoff score for the PCL-5.  Two non-clinical 
samples were available: individuals who had experienced a trauma but were not in mental health 
treatment, and individuals who had not experienced a trauma and were also not in treatment. For 
treatment outcome purposes, the non-clinical sample that endorsed a traumatic experience was 
determined to be the most likely comparison group for a clinical trauma sample, although a 
proposed clinical cutoff was calculated for each group. Results revealed a RCI of 12, indicating 
that a 12-point change between PCL-5 pretest and posttest scores is indicative of reliable change.  
Further, results determined a clinical cutoff score of 27, which suggests scores of 27 or above are 
more likely to fall within the clinical population and scores below 27 are more likely to fall 
within the non-clinical population.  The findings of this study could be used to aid clinician use 
of the PCL-5 for evaluating treatment outcome. 
Keywords: PCL-5, Reliable Change Index (RCI) for PCL-5, clinical cutoff score for PCL-5   
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Introduction 
When individuals seek mental health treatment, they question whether therapy will work 
for them.  Their symptoms have passed the threshold of tolerance and they come to the 
conclusion they can no longer function without additional support.  They want to function better 
in their daily lives and they want their symptoms to decrease.  They want to feel better.  How can 
we, as clinicians, determine whether our interventions are helping provide relief for our clients?   
Numerous quantitative measurements have been developed to assist in determining 
improvement or deterioration in therapy.  However, if changes in scores are observed on the 
quantitative measurements, clinicians should not necessarily interpret the change in scores as 
proof of improvement or deterioration.  Instead, clinicians should determine whether those 
changes in scores are significant before determining whether their clients have improved or 
deteriorated.  Significant change can be determined by computing whether the change is 
statistically significant or whether the change is clinically significant.  Throughout history there 
has been a debate as to whether statistical significance or clinical significance provides better 
insight into whether change seen on quantitative measurements is meaningful or not (LeFort, 
2007).  However, according to LeFort (2007), there is a general agreement that statistical 
significance tests do not provide information about the practical or clinical importance of 
research results.  Further, tests of clinical significance provide clinicians with more information 
on the clinical implications of the changes seen on the quantitative measures.  Therefore, one 
tool clinicians use to determine whether clients are improving or deteriorating based on changes 
seen on their assessment scores is clinical significance. 
Clinical significance is a tool used to measure the impact of treatment and to quantify 
clients’ progress.  Clinical significance allows clinicians to determine whether their clients are 
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experiencing tangible and significant decreases in symptoms (Kazdin, 1999).  Jacobson, Follette, 
and Revenstorf (1984) were the first to suggest the importance of using clinical significance to 
the field of psychology.   They suggested that using clinical significance could determine 
whether therapy, and more specifically treatment interventions, were effectively adequate that 
clients no longer met criteria for their diagnoses.  Further, clinical significance allows clinicians 
to quantify the results of participation in therapy and report it to their clients in a way they can 
understand (Jacobson, Roberts, Berns, & McGlinchey, 1999).  Using clinical significance to 
determine the effectiveness of therapy interventions allows clients to answer the question: is 
therapy working for me; am I getting better? 
Determining clinical significance traditionally involves a two-step process that involves 
determining reliable change and clinical cutoff scores.  First, reliable change allows clinicians to 
determine whether a change in clients’ scores, whether in a positive or negative direction, is a 
result of true change or is a result of measurement error.  Second, establishing a clinical cutoff 
score allows clinicians to determine whether clients’ scores are more closely associated with 
individuals who are clinically distressed and are receiving mental health treatment compared to 
individuals who are not clinically distressed and are not receiving mental health treatment 
(Jacobson & Truax, 1984).   
Clinical Cutoff Scores 
According to Jacobson and Truax (1991), establishing a clinical cutoff point measures 
clients’ functioning and separates the ‘non-clinical’ population from the ‘clinical’ population.  
There are three options to consider using to establish the clinical cutoff point—Cutoff A, Cutoff 
B, and Cutoff C.   
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 Cutoff point A has high sensitivity and is established when an individual’s score moves 
from being within the clinical population towards being in the non-clinical population.  Jacobson 
and Truax (1991) define Cutoff point A as being, “two standard deviations beyond (in the 
direction of functionality) the mean for that population” (p. 13).  When the non-clinical mean is 
lower than the clinical mean, the equation for Cutoff A is as follows: Mclinical – 2SDclinical 
When the non-clinical mean is higher than the clinical mean, the equation for Cutoff A is as 
follows: Mclinical + 2SDclinical 
Cutoff B has high specificity; however, it can only be used when non-clinical data is 
available.  Jacobson and Truax (1991) defined Cutoff B as, “the point 2 SD within a recognized 
non-clinical mean” (p. 13).  The overlap between the functional and non-functional groups found 
when using this Cutoff B makes this cutoff the most lenient of the three cutoff options (Jacobson 
& Truax, 1991).  When the non-clinical mean is lower than the clinical mean, the equation for 
Cutoff B is as follows: Mnon-clinical – 2SDnon-clinical 
When the non-clinical mean is higher than the clinical mean, the equation for Cutoff B is as 
follows: Mnon-clinical + 2SDnon-clinical 
According to Jacobson et al. (1999), Cutoff C is based on the theory that suggests relative 
probability will ensure that scores will fall into one category and not the other.  Cutoff C can be 
defined as a weighted midpoint between the means of the clinical and the non-clinical 
populations; therefore, the calculation requires the availability of normative data for both a 
clinical and a non-clinical group (Jacobson & Truax, 1991).  The equation for Cutoff C is as 
follows:    
Cutoff C = (SDNon-clinical MClinical) + (SDClinicalMNon-clinical) 
                                                  SDClinical + SDNon-clinical 
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Jacobson and Truax (1991) provide recommendations for utilizing the three cutoff points.  
The authors recommend that first, if normative data is available, clinicians should use Cutoff B or 
C before using Cutoff A.  Second, Cutoff C is superior when non-clinical data is available and 
there is an overlap between the clinical and non-clinical distributions.  Third, if non-clinical data 
is available, but there is no overlap between the clinical and non-clinical distributions, using 
Cutoff B is recommended.  Last, Cutoff A is the only option when non-clinical normative data is 
unavailable.    
Unfortunately, non-clinical normative data are rarely collected or published, making the 
most recommended cutoff point (Jacobson & Truax, 1991), Cutoff C, impossible for clinicians to 
use.  Further, without the aid of Cutoff C, clinicians are unable to determine whether their 
clients’ symptoms are more similar to the clinical or non-clinical population.  The proposed 
study aims to collect non-clinical data in order to utilize Cutoff C, which will aid in filling this 
gap in information.  
Reliable Change Index 
 Client progress can be observed through interactions and can be quantified using 
assessment measures over time.  However, using observation and assessment alone to gauge 
client progress is not sufficient.  As clinicians, we need to have another tool to help determine 
whether the observed change is true change.  In the field of psychology, true change is referred 
to as reliable change resulting from a client’s involvement in a specific intervention, as opposed 
to change that results from clinician biases, practice effects, or measurement error (Maassen, 
2000; Hsu, 1996).  The Reliable Change Index is a tool used to determine if client progress is a 
result of reliable change. 
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 The Reliable Change Index (RCI), first introduced by Jacobson, Follette, and Revenstorf 
(1984), is used to evaluate and compare changes in clients’ pretest and posttest scores on 
assessment measures.  Clinicians use the RCI to determine whether the difference between 
pretest and posttest scores is evidence of reliable change—progress following intervention 
(Jacobson et al., 1984).  Determining reliable change is an imperative part of psychotherapy 
because it answers the question of whether the client has changed significantly enough to be 
confident that the progress is a product of true change instead of measurement error (Evans, 
Margison, & Barkham, 1998).  Further, using the RCI to track client progress assists clinicians in 
determining how clients are responding to treatment, whether treatment interventions need to be 
adjusted, and when client termination is appropriate. 
 Over the course of history, several individuals have developed varying methods to 
calculate reliable change.  Although a number of methods exist, all use the same essential 
equation to compute the difference between pretest and posttest scores and all equations result in 
a standard Z score.  The equation is as follows:  𝑅𝐶 =  
𝑌−𝑌′
𝑆𝐸
  where the numerator, Y-Y’, refers 
to the difference between the pretest and posttest scores.  According to Hinton-Bayre (2010), the 
most appropriate way to calculate the denominator, the standard error, has been the highest 
contention between the various methods for calculating reliable change. 
Methods for Calculating Reliable Change 
 The various methods for calculating reliable change can be categorized into two groups—
estimation interval methods and null hypothesis methods.  The two differences between groups 
are the way in which true change is evaluated and the way in which the standard error is used 
(Shada, 2013).  According to Maasson, Bossema, and Brand (2009), the estimation interval 
methods use normative data from the sample or population to estimate true change; whereas, the 
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null hypothesis method uses the observed change as an estimate of true change, which is 
advantageous because the observed change is unbiased compared to using normative data.  Using 
different methods for calculating reliable change can result in different assumptions regarding 
the effect of a treatment intervention on a client (Shada, 2013).  Therefore, it is imperative as 
clinicians to be informed of the varying methods for calculating reliable change in order to 
choose the most suitable method.  The following sections will include descriptions of the various 
methods for calculating reliable change: the Jacobson and Truax Method, Gulliksen-Lord-
Novick Method, Edwards-Nunnally Method, and the Hageman-Arrindells Methods. 
Jacobson and Truax Method.  The Jacobson and Truax (JT) method is a null hypothesis 
method of evaluating clinically significant change (Maassen, 2001) and is consistently one of the 
most used methods for analyzing change (Maassen, 200IV).  The JT method was developed after 
Jacobson and Truax suggested that, through the course of therapy, clients’ progress from 
experiencing symptoms that fall within a clinical range to experiencing symptoms that then fall 
within a non-clinical range.  Jacobson et al. (1999) reported that the JT method uses “a twofold 
criterion for clinically significant change: (a) The magnitude has to be statistically reliable and 
(b) by the end of therapy, clients have to end up in a range that renders them indistinguishable 
from well-functioning people” (p.300).  The authors theorized that only when clients’ symptoms 
changed reliably from clinical range to non-clinical range could the change be considered 
clinically significant.  Further, the JT method provides a classification system for client progress 
over time—deteriorated, unchanged, improved, or recovered in order to rule out change resulting 
from measurement error (Jacobson, Follette, & Ravenstrof, 1986).  The classification system is 
explained by Jacobson et al.:  
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By applying our metric to a population of treated clients, one can determine the 
percentage of clients who improved but did not recover, the percentage of clients who 
recovered, and the percentage of clients who remained unchanged or who deteriorated in 
each treatment condition (p. 300). 
An adaptation was made to the original method proposed to account for differences 
between initial and final variance in scores (Jacobson & Truax, 1991).  Further, the adapted two-
step process is empirically supported, making it a preference over the original method 
(Maasseen, 2004), and it also analyzes the pre- and posttest scores as two distinct distributions, 
which accounts for the unreliability seen in pre- and posttest scores (Hageman & Arrindell, 
1993). 
After choosing the appropriate cutoff point, the next step in the JT model is to determine 
whether the clients’ progress is a result of growth in positive characteristics and decrease in 
negative symptoms, as opposed to a result of measurement error.  To obtain this information, the 
JT method uses a Reliable Change Index (RCI), which is an assessment tool that helps determine 
statistically significant reliable change by utilizing the assessment tools’ psychometric properties 
(Maasseen, 2004).  Change, not due to measurement error, is determined when individuals’ 
scores pass the statistically determined RCI in a positive direction (Shada, 2013).   
The original recommendation for calculating the RCI was to subtract the posttest score 
from the pretest score then divide the difference by the standard error of measurement (SE)—the 
test-retest reliability estimate.  When using this calculation, an increase in change was required to 
achieve a statistically reliable change if the assessment instrument’s psychometric properties 
were less reliable than other measurements (Wise, 2004).  In time, this calculation was updated 
by Christensen and Mendoza (1986) who proposed that instead of using the SE in the equation, 
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individuals should use Sdiff, the difference between any two scores obtained on the same test by 
the same individual to assess for measurement error.  The equation for the JT method is as 
follows: 
𝑌−𝑌′
√2(𝑆𝐸)2
 
 After completing the two-step JT method, clinicians can then determine which 
classification best describes their clients’ progress by using the most appropriate cutoff point and 
the calculated RCI.  For example, individuals would be classified as recovered if their scores 
exceeded the cutoff and the RCI in a positive direction; improved if their scores passed the RCI 
in the positive direction, but did not pass the cutoff point; unchanged if they did not pass either 
the cutoff point or the RCI; and last, individuals would be classified as deteriorated if they 
passed the RCI in the negative direction (Atkins, Bedics, McGlinchey, & Beauchaine, 2005).  
Gulliksen-Lord-Novick Method.  The Gulliksen-Lord-Novick (GLN) method proposes 
that individuals’ pre-treatment and post-treatment scores can be conceptualized as parallel 
measurements when no treatment effects exist.  Thus, standard errors of measurements are equal 
for pre- and post-test scores (Hsu, 1999a).  The GLN method differs from the JT method because 
it uses the hypothesized population mean of a relevant group to control for regression to the 
mean; retest scores are used if the population is unavailable (Bauer, Lambert, & Nielsen, 2004).  
According to Marsden (2010), the GLN method produces a more conservative assessment of 
reliable change compared to the RCI used in the JT method. 
Edwards-Nunnally Method.  The Edwards-Nunnally (EN) method was proposed by 
Speer (1995), who advocated for the inclusion of confidence intervals when calculating reliable 
change.   By using confidence intervals approximately two standard deviations based on 
individuals’ true score helps establish whether individuals are improving or deteriorating 
(Jacobson et al., 1999).  The GLN method utilizes individuals’ post-test scores relative to an 
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established confidence interval around the estimate of the individuals’ pre-test score (Wise, 
2004).  This method decreases the influence of regression to the mean, which improves clinical 
significance (Bauer et al., 2004).  According to Marsden et al. (2010) and Wise (2004), the GLN 
method produces conservative results—less incidence of individuals being categorized as 
reliably improved and more incidents of individuals categorized as reliably deteriorated. 
Hageman-Arrindells Method.  The Hageman-Arrindells (HA) method was developed to 
improve upon the pre-post difference score by taking regression to the mean into account 
(Hageman & Arrindell, 1999).  The HA method expands beyond the EN method; the HA method 
adjusts for error and estimates the underlying true score, whereas the EN method uses observed 
scores (Wise, 2004).  The HA method produces two levels for differential analysis of change—
the individual level and the group level (Bauer et al., 2004).  According to Jacobson et al. (1999), 
the individual level distinguishes which classification the scores fall within and the group level 
distinguishes the proportion of improvement estimations.  The HA method uses the reliability of 
the difference scores (rdd), which compares individuals’ change scores to the change scores in the 
classification the scores fall within.  The reliability of differences score must reach a minimum 
threshold, giving increased estimation accuracy (Marsden et al., 2010).  
Comparison of RCI Methods: Which Is Best?  
  With several methods of calculating reliable change, it is no surprise there has been 
historical disagreement on which method is best.  A number of studies have been conducted in 
an attempt to answer the question of which is best at assessing change (McGlinchey & Jacobson, 
1999; McGlinchey, Atkins, & Jacobson, 2002; Bauer, Lambert, & Nielsen, 200IV; & Atkins, 
Bedics, McGlinchey, & Beauchaine, 2005).  McGlinchey and Jacobson (1999) compared the HA 
method to the JT method using the same data set Jacobson and Truax (1991) used to develop the 
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JT method.   The data set included outcomes from the Dyadic Adjustment Scale (DAS; Spanier, 
1976) and the global distress scale of the Marital Satisfaction Inventory (GDS; Snyder, 1979) 
collected from couples in marital therapy.  Results from this study suggest the JT and HA 
methods establish similar results; however, McGlinchey and Jacobson (1999) reported that the 
JT method is more ideal, due to its simplistic calculation, and therefore should be used over the 
HA method. 
McGlinchey et al. (2002) compared four RCI methods—JT, GLN, EN, and HA.  Each 
method was used to evaluate the accuracy in predicting substance abuse relapse.  The results of 
this study indicate the HA method resulted in the least amount of individuals classified as 
recovered, making the HA method the most conservative of the four methods examined.  
However, the results also indicate no other method of calculating reliable change was superior to 
the JT method.  McGlinchey et al. concluded that the JT method was preferable over the other 
three methods. 
 Atkins et al. (2005) compared the JT, GLN, HA, and EN methods in an attempt to help 
clinicians better understand the differences between the methods.  The authors utilized 
simulation data of pre-therapy and post-therapy estimates established from several clinical trials.  
The results suggest that, as the reliability of the measure increased, the agreement between 
methods increased.  Further, few differences were apparent at the reliability level most often 
used in psychotherapy research, .90.  However, at a reliability of .90, the EN method resulted in 
the smallest standard error and the HA method resulted in the fewest cases classified as 
recovered.  This suggests that, at a level of reliability used in psychotherapy research, the EN 
method and the HA method allow for more variance than the other methods.  Last, the JT and 
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GLN methods produced approximately identical classifications; therefore, Atkins et al. 
recommend the using the JT or the GLN methods. 
Altogether, according to the research conducted to answer the question of which method 
of calculating reliable change is better, it appears the JT method is most widely recommended.  
Therefore, the JT method will be used to calculate reliable change and clinical cutoff for the 
current study. 
Treatment Outcome Measurements for PTSD 
 As with other diagnoses, there are several different methods for assessing PTSD 
symptoms.  The least detailed option for assessing PTSD symptoms is basic screening forms.  
PTSD screening forms include, but are not limited to, the Primary Care PTSD Screen (PC-
PTSD), the Short Screening Scale for PTSD, the Short Post-Traumatic Stress Disorder Rating 
Interview (SPRINT), and the Trauma Screening Questionnaire (TSQ).  These screening tools are 
quick to administer, but may not capture adequate detail for use as treatment outcome measures. 
Using structured interviews, such as the Structured Clinical Interview (SCID) and the Clinician 
Administered PTSD Scale (CAPS), are a more detailed and in-depth option for assessing PTSD 
symptoms, but also take a great deal of time to administer and score.  Last, the most user-friendly 
and accessible option is self-report checklists.   
 Several PTSD self-report checklists exist; however, they are not all alike.  Some of the 
checklists are based on DSM criteria to allow clinicians to use them as diagnostic tools and 
treatment outcome measures; others are not mapped to DSM criteria and are only intended to be 
used for treatment outcome.  Self-report measures that are based on DSM criteria include, but are 
not exhaustive to, the following: The PTSD Screening and Diagnostic Scale (PSDS; Kubany et 
al., 2000)), a 38-item self-report measure that includes a 4-part inventory that assesses for PTSD 
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using the DSM-IV-TR criteria and the Los Angeles Symptom Checklist (LASC; King et al., 
1995), a 43-item self-report measure that does not exclusively assess for any specific trauma; 
however, it does assess for the presence of symptoms in the past month.  The 17 DSM-IV 
symptoms of PTSD are embedded into the items that assess for more general psychological 
distress.  An example of a self-report measure for PTSD that is not based on DSM criteria for 
PTSD is the Trauma Symptom Checklist -40 (TSC-40; Briere & Runtz, 1989), which measures 
aspects of posttraumatic stress, as well as other symptoms typically seen in traumatized 
individuals.  Another example is the Impact of Event Scale – Revised (IES-R; Weiss & Marmar, 
1996), a 22-item self-report measure designed to assess subjective distress resulting from 
traumatic events.  Items on the IES-R correspond to 14 of the 17 PTSD symptoms seen in the 
DSM-IV. 
 Due to the significant changes to the PTSD criteria seen in the DSM-5, the vast majority 
of the self-report PTSD measures designed to aid in diagnosis are no longer valid.  Two 
measures that have been updated for the DSM-5, as of this writing, are the CAPS and the PCL.  
However, due to the recentness of their update, no psychometric data has been published for the 
revised editions.   
Changes in DSM-5 Criteria for PTSD 
Several changes have been made to the criteria for PTSD in the Diagnostic and Statistical 
Manual of Mental Disorders (5th ed.; DSM-5; American Psychiatric Association, 2013).  PTSD 
is no longer classified under the anxiety disorder chapter; rather, it is classified under a new 
chapter to the DSM—Trauma- and Stressor-Related Disorders (American Psychiatric 
Association, 2013a).   
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Language 
The DSM-5 more clearly defines what constitutes a traumatic event.  For example, sexual 
violence as an explicit form of trauma was added to Criterion A; the DSM-IV-TR Criterion A 
only considered actual or threatened death or serious injury, which inexplicitly encompassed 
sexual violence, or a threat to the physical integrity of self or others as traumatic events.  Further, 
Criterion A can now be met if individuals learn that a traumatic event occurred to a close family 
member or close friend, or as a result of repeated or extreme exposure to aversive details of 
traumatic events (i.e., situations police officers and first responders repeatedly encounter).  Last, 
the language used in the DSM-IV-TR to describe individuals’ reactions to traumatic events 
(intense fear, helplessness, and horror) have been removed as this criterion was not useful in 
predicting the onset of PTSD (American Psychiatric Association, 2013b).   
Clusters 
The PTSD criteria are now categorized into four diagnostic clusters, as opposed to the 
three clusters seen in DSM-IV-TR.  The clusters are re-experiencing, avoidance, negative 
cognitions and mood, and arousal.  Re-experiencing refers to spontaneous memories of the 
traumatic event, recurrent dreams related to the event, flashbacks, and other intense or prolonged 
psychological distress.  Avoidance refers to avoiding distressing memories, thoughts, feelings, 
and external reminders of the event.  Negative cognitions and mood represents a variety of 
feelings—from persistent and distorted sense of blame of self or others, to estrangement from 
others or markedly diminished interest in activities, to an inability to remember key aspects of 
the traumatic event.  Arousal refers to aggressive, reckless or self-destructive behavior, sleep 
disturbances, and hypervigilance.  Further, the DSM-5 accounts for the “fight” reaction often 
seen in arousal, as opposed to just the “flight” aspect addressed in the DSM-IV-TR.  The number 
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of symptoms that must be endorsed depends on the specific cluster (American Psychiatric 
Association, 2013b).   
Timeframe and Subtypes 
The DSM-5 only requires that the disturbance continue for more than a month and 
eliminates the division between acute and chronic PTSD.  However, the DSM-5 now includes a 
preschool subtype and a dissociative subtype.  The preschool subtype can be applied to children 
younger than age 6 who have experienced a traumatic event and are experiencing subsequent 
marked distress.  The dissociative subtype can be applied when individuals experience prominent 
dissociative symptoms, along with the other symptoms.  Dissociative symptoms include 
experiences of feeling detached from one’s own mind or body, and experiences in which the 
world seems unreal, dreamlike, or distorted (American Psychiatric Association, 2013b). 
Several clinical implications result from the numerous changes to the PTSD criteria 
found in the DSM-5.  More specifically, what do the changes to the PTSD criteria mean for 
treatment outcome measures designed to assess for PTSD that were developed using the DSM-
IV criteria?  The treatment outcome measures used in PTSD treatment that were developed using 
the DSM-IV-TR may no longer be valid, especially for purposes of diagnostic assessment; they 
must be updated to map to the new DSM-5 criteria for PTSD.  
PTSD Checklist for DSM-5 
 The PTSD Checklist for DSM-5 (PCL-5) is a 20-item self-report measure that has been 
updated to assess the 20 PTSD symptoms found in the DSM-5 (Weathers et al., 2013).  The 
PCL-5 can be used to evaluate and monitor symptom change during and after treatment, screen 
individuals for PTSD, and make provisional PTSD diagnoses.   
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Changes from Previous PCL for DSM-IV-TR 
 Several revisions were made to the PCL to update it for the new DSM-5 criteria for 
PTSD.  First, the PCL for DSM-IV-TR has three versions—PCL-M (military), PCL-C (civilian), 
and PCL-S (specific); the PCL-5 is most similar to the PCL-S (specific) version.  Currently, 
there are no updated versions of the PCL-M or PCL-C for the DSM-5 PTSD criteria (Weathers et 
al., 2013).  Second, as mentioned above, there are three formats in which the PCL-5 can be 
administered: without Criterion A, which is typically used when exposure to trauma is evaluated 
with another method; with a brief Criterion A assessment; and with the revised Life Events 
Checklist for DSM-5 and extended Criterion A assessment (Weather et al., 2013).  Third, the 
changes in language found in the DSM-5 criteria for PTSD are reflected in the PCL-5.  Fourth, 
the rating scale used on the self-report changed from a 5-point Likert scale ranging from 1-5 to a 
scale ranging from 0-4; however, the rating scale descriptions remain the same—“Not at all,” “A 
little bit,” “Moderately,” “Quite a bit,” and “Extremely.”  Importantly, due to the change in 
rating scale, along with the increase from 17 to 20 items, PCL-5 scores are not compatible with 
the PCL for DSM-IV-TR scores and are not interchangeable (Weathers et al., 2013).  
Administration and Scoring 
 The PCL-5 takes approximately 5-10 minutes to complete and should be interpreted by 
the clinician (Weather et al., 2013).  There are several ways to score the PCL-5.  The total 
symptom severity score is obtained by summing the scores for each of the 20 items; the total 
symptom severity score ranges from 0-80.  The DSM-5 symptom cluster severity scores are 
obtained by summing the scores for the items within a given cluster.  Further, a provisional 
PTSD diagnosis can be made by conceptualizing each item rated as two “Moderately” or above 
as an endorsed symptom and then follow the DSM-5 diagnostic rule, which requires at least 1 
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item from cluster B, 1 item from cluster C, two items from cluster D, and two items from cluster 
E.  Cutoff scores appear to be, given the limited preliminary validation research, 11-14 points 
lower than the PCL for DSM-IV-TR cutoff points, with closer to an 11-point difference for more 
conservative cutoff scores and closer to a 14-point difference for less conservative cutoff scores.  
A cutoff score of 33 for the PCL-5 appears to be a reasonable value; however, further research 
on the psychometric properties of the PCL-5 are necessary (Weathers et al., 2013).  
Unfortunately, no research is available on how the cutoff points were developed.  This highlights 
the necessity to develop research-based cutoff points to better determine when clients’ symptoms 
are more similar to individuals in a clinical population versus individuals in a non-clinical 
population. 
Measuring Change 
According to Weathers and colleagues (2013), a 5-10 point change represents reliable 
change on the PCL for the DSM-IV-TR PTSD criteria.  Further, a 10-20 point change represents 
clinically significant change.  The authors recommended using 5 points as a minimum threshold 
for determining clinical change using the PCL for DSM-IV-TR.  Although cutoff scores and 
reliable change data are not currently available for the PCL-5, Weathers et al. (2013) suggest 
they will be within a similar range to the PCL for the DSM-IV-TR.  Unfortunately, there is no 
information on how these values were generated, which creates an issue for clinicians who want 
to use the measure to determine reliable change.   
Improving Upon the PCL-5 Research: Current Study 
 Although most adult self-report questionnaires for PTSD include recommendations of 
values to determine clinical change; unfortunately, the recommended values are not calculated 
using a RCI.  Therefore, clinicians may be determining whether their clients have made progress 
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by using the recommended change values; however, clinicians do not have a way of determining 
whether the change in symptoms is a result of true change or a result of measurement error.  
Further, no non-clinical normative data has been published for many of the self-report measures, 
including the PCL-5.  This is an incredible hindrance for clinicians because it makes using the 
most generally recommended cutoff calculation, Cutoff C, impossible when determining whether 
their clients’ symptoms are more similar to the clinical or non-clinical population.   
 Therefore, the purpose of the current study is to collect data from a non-clinical 
population to aid in the process of determining clinical and non-clinical cutoff scores for the 
PCL-5.  Developing a RCI and clinical/non-clinical cutoff scores for the PCL-5 will support 
clinicians in providing the best care for their clients by allowing them to quantify their clients’ 
progress and determine whether treatment interventions are providing clinically significant 
changes.  Establishing a non-clinical/clinical cutoff score for the PCL-5 will also help clinicians 
determine whether their clients’ scores on the measure are more closely associated with 
individuals who are clinically distressed and in mental health treatment versus individuals who 
are not clinically distressed and are not in mental health treatment.  Further, collecting data from 
a non-clinical sample is imperative for PTSD assessment because it will help identify individuals 
who have experienced a trauma, but that have developed sub-threshold symptoms and, thus, do 
not seek out mental health treatment. 
Method 
Participants 
Participants included adults in the United States, age 18 and older, from various age, sex, 
race, education, and geographic location groups  (N=205).  In order to participate, participants 
needed to be literate in the English language and have access to a computer with an internet 
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connection.  Based on a review of psychometric properties of PTSD measures research, the 
number of participants sampled ranged from 40 to 392 (Creamer, Bell, & Failla, 2003; Ruggiero, 
Ben, Scotti, & Rabalais, 2003; Blanchard, Jones-Alexander, Buckley, & Forneris, 1996; Coffey 
et al., 1998).  Therefore, the obtained 205 participants fall within the typical number of 
participants recruited for smaller psychometric research.   
 Participants were recruited using MTurk, an online marketplace that allows individuals to 
get paid for completing online tasks, including research surveys (Buhrmester, Kwang, & 
Gosling, 2011).  According to Buhrmester, Kwang, and Gosling (2011), regardless of the amount 
the individuals are paid to complete psychological research studies—even at the lowest 
compensation level of two cents—the quality of the collected data was not affected.  The authors 
concluded that MTurk is a reliable method to collect survey data.  Participants were compensated 
with 10 cents for completing the survey.  Participants were also recruited using the snowball 
method using psychology listservs, Facebook, family members, friends, and colleagues to 
distribute the survey. 
The mean age of participants was 36.40 (SD=13.83).  In regard to trauma and mental 
health treatment, 14.1% of participants had experienced a traumatic event and were engaging in 
mental health treatment (clinical group); 54.1% of participants had experienced a traumatic 
event, but were not engaging in mental health treatment (non-clinical group); 26.8% of 
participants had not experienced any traumatic events and were not engaging in mental health 
treatment (non-clinical/non-trauma group); and 4.9% of participants had not experienced any 
traumatic event, but were engaging in mental health treatment (clinical/non-trauma group).  
Other sample characteristics are described in Table 1. 
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Table 1 
Sample Characteristics 
 
Characteristics 
 
Percentage 
 
Characteristics 
 
Percentage 
Sex 
    Male 
    Female 
    Transgender 
Race 
    White 
    Hispanic or Latino 
    Black or African American 
    Asian/Pacific Islander 
    Native American 
    Multi-racial  
Highest Level of Education 
Achieved  
    9th grade 
    11th grade 
    High school diploma/GED 
    Less than one year of college 
    One or more years of college 
    Associate degree 
    Bachelor degree 
    Master degree 
    Doctorate degree 
    Professional degree 
 
25.4 
73.2 
1.0 
 
82.9 
5.4 
5.4 
2.9 
1.0 
2.4 
 
 
1.0 
2.4 
8.8 
5.4 
15.6 
9.8 
28.3 
23.9 
3.9 
1.0 
Geographic Region 
    West 
    Mid-West 
    South 
    East 
Household Income 
    Less than $10,000 
    $10,000-$19,000 
    $20,000-$29,000 
    $30,000-$39,000 
    $40,000-$49,000 
    $50,000-$59,000 
    $60,000-$69,000 
    $70,000-$79,000 
    $80,000-$89,000 
    $90,000-$99,000 
    $100,000-$149,000 
    $150,000 or more 
 
 
51.9 
19.3 
24.8 
3.8 
 
           11.2 
6.8 
9.3 
10.2 
9.8 
8.3 
9.3 
8.3 
1.5 
5.4 
11.7 
6.3 
 
Measures 
 Demographic Questionnaire. The demographic questionnaire (Appendix A) asked 
specific questions regarding participants’ age, sex, race, level of education, household income, 
and geographic location to determine the representation of the sample compared to the 
population of the United States. 
PCL-5 (Weathers et al., 2013). The PCL-5 (Appendix B), as previously described, is an 
adult self-report measure that assesses for PTSD.  The PCL-5 can be administered using three 
different versions.  For the purposes of this study, participants were administered the PCL-5 
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version that includes the brief Criterion A questions and the symptom checklist.  To test internal 
consistency of the reliability of PCL-5 scores, Cronbach’s alpha was conducted for each group, 
as well as for the total sample.  The alpha coefficient for the clinical group was (α = .97), for the 
non-clinical group it was (α = .95), for the non-clinical/non-trauma group it was (α = .91), for the 
clinical/non-trauma group it was (α = .91), and for the total sample it was (α = .96).  All alpha 
coefficients suggest high internal consistency and scale reliability.   
Procedure 
 Upon opening the link to the survey, participants were presented with the informed 
consent document, which they were instructed to review.  Participants were reminded their 
responses would be anonymous and that they were not required to respond to any question they 
did not feel comfortable answering.  Participants who consented to completing the online survey 
were directed to the demographic questionnaire section of the survey, and those who did not 
consent were directed to an exit page with debriefing information.   
After completing the demographic questionnaire section of the survey, participants were 
then directed to the PCL-5 section of the survey.  Participants were first asked to answer the 
Criterion A question: Have you ever experienced a traumatic event?  For example, a very 
stressful experience involving actual or threatened death, serious injury, or sexual violence.  It 
could be something that happened to you directly, something you witnessed, or something you 
learned happened to a close family member or close friend.  Participants were then asked, Are 
you currently receiving mental health treatment?  Regardless of the response, participants were 
then presented with the PCL-5 symptom checklist.  This process was established to differentiate 
between clinical and non-clinical participants.   
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All individuals, regardless of whether they consented to participate in the study, were 
directed to a debriefing section prior to exiting the survey.  The debriefing section provided a 
website (http://www.healthy place.com/other-info/resources/mental-health-hotline-numbers-and-
referral-resources/) with various mental health hotline numbers in the case of emotional distress 
following the survey.  Due to the nature of an online survey, in-person debriefing is not an 
option; therefore, including a page with a referral website for crisis intervention hotline numbers 
allowed the participants who experienced emotional distress following the survey to debrief with 
another individual via crisis hotline options.   
Analyses.  First, data were categorized into three groups: 1) Group 1 (Clinical sample)—
participants who experienced a traumatic event and were engaged in mental health treatment; 2) 
Group 2 (Non-clinical sample)—participants who experienced a traumatic event, but were not 
engaged in mental health treatment; and 3) Group 3 (Non-clinical, Non-trauma sample)—
participants who had not experienced a traumatic event and were not engaged in mental health 
treatment.  Individuals who indicated they had not experienced a trauma, but who were receiving 
mental health care, were excluded from analysis as not fitting into either a non-clinical sample or 
a trauma sample. The mean and standard deviation of scores on the PCL-5 were calculated for 
each group.  Characteristic statistics for age, gender, race, geographic region, level of education, 
and household income were also calculated for each group.  Second, using the standard deviation 
of PCL-5 scores from Group 1 (Clinical sample) and Cronbach’s alpha, the reliable change index 
(RCI) was calculated. 
Third, using the procedure documented in Bauer et al. (2004), clinical significance was 
determined by calculating Cutoff C.  Cutoff C was calculated using the means and standard 
deviations from Group 1 (Clinical sample) and Group 2 (Non-clinical sample).  An alternate 
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Cutoff C was also calculated using the means and standard deviations from Group 1 (Clinical 
Sample) and Group 3 (Non-clinical, Non-trauma sample). 
Results 
Descriptive data for the three groups are provided in Table 2. 
Table 2 
Means, Standard Deviations, and Ranges for Study Groups 
PCL-5 Scores (Range = 0-80) n M SD Minimum Maximum 
Group 1: Clinical sample 
 
29 33.66 21.27 2 80 
Group 2: Non-clinical sample 
 
111 20.93 17.36 0 65 
Group 3: Non-clinical, Non-
trauma sample 
55 7.47 8.60 0 40 
 
Group characteristics for Group 1 (Clinical Sample) are provided in Table 3. 
Table 3 
 
Group 1 (Clinical Sample) Characteristics (N=29) 
 
Characteristics (Range) 
 
Percentage 
 
       Characteristics 
 
Percentage 
Sex 
    Male 
    Female 
Age (18-57) 
Race 
    White 
    Hispanic or Latino 
    Black or African American 
    Native American 
    Multi-racial  
Highest Level of Education 
Achieved     
    High school diploma/GED 
    Less than one year of college 
    One or more years of college 
    Associate degree 
    Bachelor degree 
    Master degree 
    Doctorate degree    
 
20.7 
79.3 
 
 
75.9 
6.9 
10.3 
3.4 
3.4 
 
 
6.9 
3.4 
27.6 
10.3 
27.6 
13.8 
10.3 
     Geographic Region 
           West 
           Mid-West 
           South 
           East 
     Household Income 
          Less than $10,000 
          $10,000-$19,000 
          $20,000-$29,000 
          $30,000-$39,000 
          $40,000-$49,000 
          $50,000-$59,000 
          $70,000-$79,000 
          $80,000-$89,000 
          $90,000-$99,000 
         
 
 
55.1 
17.2 
17.2 
10.3 
 
24.1 
6.9 
10.3 
24.1 
3.4 
13.8 
6.9 
3.4 
6.9 
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Group characteristics for Group 2 are provided in Table 4. 
Table 4 
Group 2 (Non-Clinical) Sample Characteristics (N=111) 
 
Characteristics (Range) 
 
Percentage 
 
       Characteristics 
 
Percentage 
Sex 
    Male 
    Female 
    Other                                              
Age (18-77) 
Race 
    White 
    Hispanic or Latino 
    Black or African American 
    Native American 
    Multi-racial  
    Asian or Pacific Islander              
Highest Level of Education 
Achieved     
    9th 
    11th 
    High school diploma/GED 
    Less than one year of college 
    One or more years of college 
    Associate degree 
    Bachelor degree 
    Master degree 
    Doctorate degree  
    Professional degree       
 
26.1 
71.2 
   1.8 
 
 
81.1 
5.4 
5.4 
0.9 
2.7 
     3.6 
 
 
1.8 
2.7 
9.9 
7.2 
18.0 
9.9 
28.8 
18.0 
2.7 
0.9 
     Geographic Region 
           West 
           Mid-West 
           South 
           East 
    Household Income 
           Less than $10,000 
           $10,000-$19,000 
           $20,000-$29,000 
           $30,000-$39,000 
           $40,000-$49,000 
           $50,000-$59,000 
           $70,000-$79,000 
           $80,000-$89,000 
           $90,000-$99,000 
           $100,000-$149,999 
           $150,000 or more   
 
 
45.9 
17.1 
34.2 
2.7 
 
8.1 
7.2 
9.0 
9.0 
13.5 
6.3 
10.8 
0.9 
6.3 
11.7 
3.6 
 
 
 
 
 
 
 
 
Running head: NON-CLINICAL NORMATIVE DATA PCL-5                                                   
 
24 
 
Group characteristics for Group 3 (Non-Clinical, Non-Trauma) are provided in Table 5. 
Table 5 
Group 3 (Non-Clinical, Non-Trauma) Sample Characteristics (N=55) 
 
Characteristics (Range) 
 
Percentage 
 
 Characteristics 
 
Percentage 
Sex 
    Male 
    Female                                            
Age (18-70) 
Race 
    White 
    Hispanic or Latino 
    Black or African American 
    Asian or Pacific Islander              
Highest Level of Education 
Achieved     
    11th 
    High school diploma/GED 
    Less than one year of college 
    One or more years of college 
    Associate degree 
    Bachelor degree 
    Master degree 
    Doctorate degree  
 
21.8 
78.2 
 
 
87.3 
5.5 
3.6 
     3.6 
 
 
1.8 
7.3 
3.6 
5.5 
10.9 
27.3 
40.0 
3.6 
Geographic Region 
           West 
           Mid-West 
           South 
           East 
Household Income 
    Less than $10,000 
    $10,000-$19,000 
    $20,000-$29,000 
    $30,000-$39,000 
    $40,000-$49,000 
    $50,000-$59,000 
    $60,000-$69,999 
    $70,000-$79,000 
    $80,000-$89,000 
    $90,000-$99,000 
    $100,000-$149,999 
    $150,000 or more   
 
 
46.2 
20.3 
27.7 
5.5 
 
7.3 
5.5 
7.3 
5.5 
7.3 
10.9 
12.7 
3.6 
1.8 
3.6 
18.2 
14.5 
 
Reliable Change Index 
Using the standard deviation of PCL-5 scores from Group 1 (Clinical sample) and 
Cronbach’s alpha calculated for this sample (α = .96), the reliable change index (RCI) was 
calculated (RCI=12).  The calculation of RCI=12 was completed as follows: 
 RCI = 1.96 √2(𝑆𝐷𝐶𝑙𝑖𝑛𝑖𝑐𝑎𝑙√1 − 𝛼)
2 
RCI = 1.96 √2(21.27√1 − .96)2 
The RCI allows clinicians to determine whether a change in clients’ scores, whether in a positive 
or negative direction, is a result of true change or is a result of measurement error (Jacobson et 
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al., 1984).  The RCI of 12 suggests that clients who evidence a 12-point change between their 
pretest and posttest PCL-5 scores have experienced reliable change—change not due to error.    
Clinical Cutoff 
To determine a clinical cutoff point comparing the clinical sample to individuals who had 
experienced a trauma but were not receiving mental health treatment, Cutoff C was calculated 
(C=27) using the means and standard deviations from Group 1 (Clinical sample) and Group 2 
(Non-clinical sample).  The calculation of Cutoff C=27 was completed as follows: 
Cutoff C = (SDNon-clinical MClinical) + (SDClinicalMNon-clinical) 
SDClinical + SDNon-clinical 
 
 
Cutoff C = 17.36 (33.66) + 21.27 (20.93) 
                              21.27 + 17.36 
 
To determine an alternate clinical cutoff point comparing the clinical sample to 
individuals who had never experienced a trauma and were not in treatment, Cutoff C was 
calculated (C=15) using the means and standard deviations from Group 1 (Clinical sample) and 
Group 3 (Non-clinical, Non-trauma sample).  The calculation of Cutoff C=15 was completed as 
follows: 
Cutoff C = (SDNon-clinical MClinical) + (SDClinicalMNon-clinical) 
SDClinical + SDNon-clinical 
 
 
Cutoff C = 8.60 (33.66) + 21.27 (7.47) 
                              21.27 + 8.60 
 
Establishing a clinical cutoff score allows clinicians to determine whether clients’ scores 
are more closely associated with individuals who are clinically distressed and are receiving 
mental health treatment compared to individuals who are not clinically distressed and are not 
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receiving mental health treatment (Jacobson & Truax, 1984).   For purposes of treatment 
outcome, individuals who had experienced a trauma but were not receiving mental health 
treatment were determined to be the most likely comparison group for a clinical sample of 
individuals in treatment who had experienced a trauma. The clinical cutoff score (C=27) between 
these two groups indicates that clients who obtain a score of 27 or higher on the PCL-5 should be 
classified as falling within the clinical population in terms of PTSD symptoms, and clients who 
score less than 27 should be classified as falling within the non-clinical population.  
Discussion 
The PCL-5 includes recommendations of values to determine clinical change; however, 
the recommended values are not calculated using a RCI.  Therefore, when calculating the 
reliability of change, clinicians are unable to determine whether the change in symptoms is a 
result of true change or a result of measurement error.  Further, no non-clinical normative data 
have been published for the PCL-5, which is a hindrance for clinicians because it makes using 
the clinical significance Cutoff C impossible.  As a result, clinicians are unable to determine 
whether their clients’ symptoms are more similar to the clinical or non-clinical population in 
terms of PTSD severity.  Therefore, the purpose of this study was to collect data from a non-
clinical population to aid in the process of determining a RCI and clinical cutoff score for the 
PCL-5.   
The descriptive statistics of the study groups, described in Table 2, evidenced differences 
in mean PCL-5 scores between groups.  The clinical sample had the highest PCL-5 mean score 
(M=33.6) when compared to the non-clinical sample mean score (M=20.93) and the non-clinical, 
non-trauma sample mean score (M=7.47).  These results suggest that individuals who have 
experienced a traumatic event and are currently engaged in mental health treatment are 
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experiencing, on average, the highest level of distress when compared to individuals who have 
experienced a traumatic event and are not currently engaged in mental health treatment and 
individuals who have never experienced a traumatic event and are not currently engaged in 
mental health treatment.  Further, these results support the high internal consistency and scale 
reliability of the PCL-5 determined in the current study (α = .96).  In other words, the results 
indicate the items on the PCL-5 reliably measure PTSD symptoms as evidenced by the fact that 
the clinical sample had the highest mean PCL-5 scores and the non-clinical, non-trauma sample 
had the lowest mean PCL-5 scores—individuals who have experienced a traumatic event, on 
average, scored higher on the PCL-5 when compared to individuals who have experienced a 
traumatic event and are not currently engaged in mental health treatment and individuals who 
have never experienced a traumatic event and are not currently engaged in mental health 
treatment.  
The descriptive statistics of the study groups, described in Table 2, also evidenced a large 
range in minimum and maximum PCL-5 scores across all three study groups.  The clinical 
sample had a range in scores from 2 to 80, the non-clinical sample had a range in scores from 0 
to 65, and the non-clinical, non-trauma sample had a range in scores from 0 to 40.  Although the 
ranges are large across all three study groups, the clinical sample had the highest maximum score 
and the non-clinical, non-trauma sample had the lowest maximum score, which is consistent with 
the assumed high symptom severity of individuals who have experienced a traumatic event and 
sought mental health treatment when compared to the assumed lower symptom severity of 
individuals who have not experienced a traumatic event.  These results also further support the 
high internal consistency and scale reliability of the PCL-5.  It is unclear at this time, due to the 
limitations of the study (described in detail in the Limitations and Strengths section), why a 
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minimum score of 0 occurred in the clinical sample and a minimum score of two occurred in the 
non-clinical sample and the non-clinical, non-trauma sample; however, it is proposed that the 
low minimum score seen in the clinical sample may be a result of length of time between when 
the traumatic experience occurred and when the participants took the survey in the current study.  
Further, the low minimum score may also be a result of the effects of treatment interventions.  
The low minimum scores observed in the other two study groups may be a result of the 
aforementioned factors, as well as the fact that the individuals in the non-clinical group did not 
seek out mental health treatment following their traumatic experience and thus may not have 
experienced significant enough distress and the fact that the individuals in the non-clinical, non-
trauma group did not endorse experiencing a traumatic event.   
The high maximum PCL-5 score of 40 seen in the non-clinical, non-trauma group was 
surprising given that individual in this group did not endorse experiencing a traumatic event and 
thus should not have scored above the clinical cutoff score of 33 recommended by Weathers et 
al. (2013) or the proposed clinical cutoff score of 27 calculated in the current study.  Again, it is 
unclear at this time, due to the limitations of the study (described in detail in the Limitations and 
Strengths section), why the participants in the non-clinical, non-trauma group had a maximum 
score of 40; however, one possible explanation is that some participants in this group experience 
anxiety disorders, which have similar physiological symptoms to PTSD.  Another possible 
explanation for these results is the participants’ interpretation of criterion A, which was provided 
in within the survey—“Have you ever experienced a traumatic event?  For example, a very 
stressful experience involving actual or threatened death, serious injury, or sexual violence.  It 
could be something that happened to you directly, something you witnessed, or something you 
learned happened to a close family member or close friend.”  If participants misinterpreted their 
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traumatic experiences as not fitting within this criterion, they would have answered the question 
as “no” and then been classified as non-clinical, non-trauma; therefore potentially skewing the 
results if they had actually experienced a traumatic event.   
The sample characteristics of the study groups, described in Tables 3 – 5 highlight 
demographic differences between groups.  The most notable difference in demographics between 
groups was geographic region; unfortunately, the sample was not representative of the U.S. 
population.  Participants living in the West region of the U.S. made up 51.9% of the total sample 
population, 24.8% live in the South region, 19.3% live in the Mid-West region, and only 3.8% 
live in the East region.  Participants living in the West region of the U.S. made up over half of 
the study population due to the geographic location of the researcher and the limitations of the 
recruitment procedures.  As described in Tables 3 – 5, participants across all groups were 
primarily living in the West region of the U.S.—clinical sample (55.1%), non-clinical sample 
(45.9%), and non-clinical, non-trauma sample (46.2%).  The lowest percentage of participants 
are living in the East region of the U.S.—clinical sample (10.3%), non-clinical sample (2.7%), 
and non-clinical, non-trauma sample (5.5%).  Although participants across groups were mostly 
evenly distributed across the Mid-West and South regions, the non-clinical sample evidenced a 
significantly larger percentage of participants from the South region (34.2%) when compared to 
the participants living in the South region in the clinical-sample (17.2%) and a slightly larger 
percentage when compared to the participants living in the South region in the non-clinical, non-
trauma sample (27.7%).  The significantly large difference may be a result of potentially higher 
stigma surrounding engaging in mental health treatment in the South region of the U.S. 
Upon calculating the RCI in the present study, it was determined that a 12-point change 
represents a reliable change in scores.  According to Weathers et al. (2013), a 5-10 point change 
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represents reliable change on the PCL for the DSM-IV-TR PTSD criteria.  Further, a 10-20 point 
change represents clinically significant change.  Following the update to DSM-5, Weathers et al. 
(2013) recommended to continue using the above point changes to determine reliable change and 
clinically significant change for scores on the PCL-5.  Although the 12-point change score falls 
within the recommended point change range recommended by Weathers et al. (2013), having a 
specific number to recommend to clinicians is an improvement when determining reliable 
change in scores. 
Weathers et al. (2013) suggests that an appropriate cutoff score for the PCL-5 is a value 
of 33; unfortunately, no research is currently available on how this cutoff point was calculated.  
According to Jacobson et al. (1999), three cutoff points—Cutoff A, B, and C—are appropriate 
methods of calculating cutoff points.  Jacobson and Truax (1991) provide recommendations for 
utilizing the three cutoff points: 1) If  normative data is available, clinicians should use Cutoff B 
or C before using Cutoff A; 2) Cutoff C is superior when non-clinical data is available and there 
is an overlap between the clinical and non-clinical distributions; 3) If non-clinical data is 
available, but there is no overlap between the clinical and non-clinical distributions, using Cutoff 
B is recommended; 4) Cutoff A is the only option when normative data is unavailable.   
Due to the availability of both clinical and non-clinical normative data gathered during 
the present study, Jacobson and Truax’s (1991) recommendation was followed and Cutoff C was 
used to calculate the cutoff score (C=27) for the PCL-5.  Cutoff C is based on the theory that 
suggests relative probability will ensure that scores will fall into one category and not the other.  
Cutoff C can be defined as a weighted midpoint between the means of the clinical and the non-
clinical populations (Jacobson & Truax, 1991).  The cutoff score of 27 calculated in this study is 
somewhat less than the proposed cutoff score of 33 recommended by Weathers et al. (2013).  
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The discrepancy in cutoff scores is most likely related to the small clinical population sample 
size (N=29).  Further, the large range in PCL-5 scores in both the clinical sample (2-80) and the 
non-clinical sample (0-65) described in Table 2, most likely impacted the calculation.  However, 
the discrepancy may also be related to the changes seen in the PTSD criteria between the DSM-
IV-TR and DSM-5, and the resulting potential for an increase in individuals meeting criteria for 
PTSD.  Last, the discrepancy could be present due to the potential for the PCL-5 to identify 
subthreshold PTSD. 
Limitations and Strengths 
 Several limitations of this study may have influenced the results.  One limitation is the 
small total sample size because it creates the potential for measurement error and difficulty 
generalizing results due to potential issues with distribution and significance of scores.  Also, as 
mentioned above, the small clinical population sample size may have impacted the Cutoff C 
calculation and produced the noted discrepancy between the cutoff score calculated in the 
present study and the recommended cutoff score by Weathers et al. (2013).  As a result of the 
small sample sizes, generalizing and utilizing the cutoff score should be done with caution. 
Despite the small sample sizes, it is important to note that mean PCL-5 scores reflected group 
differences in an expected way, in that the clinical group had the highest mean score, the non-
clinical group had the second highest mean score, and the non-clinical, non-trauma group had the 
lowest score.  Another limitation is that the participants were primarily living in the West region 
of the U.S., which further limits generalizability of results.  Uneven distribution of participants’ 
region of residence is most likely a result of a limitation with recruitment procedures.  
Participants were primarily recruited using the snowball method using psychology listservs, 
Facebook, family members, friends, and colleagues to distribute the survey.  The region of 
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residence of the researcher—the West region of the U.S.—most likely resulted in the high 
percentage of participants from the West region.  The participants recruited using MTurk most 
likely resulted in the participants living in the other regions of the U.S. and according to 
Buhrmester, Kwang, and Gosling (2011), MTurk is a reliable method to collect survey data. 
An additional limitation was that participants who endorsed experiencing a traumatic 
event were not asked a follow up question to assess the length of time between when the 
traumatic experience occurred and when they took the survey in the current study.  As a result of 
not having this information, it makes it difficult to determine why low scores on the PCL-5 
occurred in the clinical and non-clinical groups—lower scores could have been a result of a 
longer period of time between when the traumatic experience occurred and when the survey was 
taken.  Low scores on the PCL-5 in the clinical group could have also been a result of engaging 
in mental health treatment.   
Another limitation is that participants in the clinical group were not asked whether their 
mental health treatment was trauma focused or if other mental health issues were being 
addressed.  Also, participants were not asked if they had any other mental diagnoses; this is a 
limitation because participants in the non-clinical, non-trauma group had a maximum score of 40 
on the PCL-5 and it is unclear why participants who denied experiencing a traumatic event 
would obtain a score above the clinical cutoff score of 33 recommended by Weathers et al. 
(2013) or the proposed clinical cutoff score of 27 calculated in the current study.  Assessing for 
other mental health disorders would help determine whether co-occurring or different mental 
health disorders with similar symptoms to PTSD were being touched on when participants 
answered the items on the PCL-5.  Last, participants who denied being engaged in mental health 
treatment were not asked if they had ever engaged in mental health treatment.  This is a 
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limitation because it decreases the ability to determine if participants in the non-clinical group 
have lower PCL-5 scores compared to the clinical group because of previously receiving mental 
health treatment to process the traumatic events they experienced or because of other factors 
such as lower perceived symptom severity or supportive social networks.  
 This study also has several strengths.  One strength is that it is the only study to collect 
non-clinical normative data on the PCL-5, and as a result, it is the only study to utilize the Cutoff 
C method to calculate a proposed cutoff score.  It is also the only study to calculate a proposed 
RCI.  Although Weathers et al. (2013) recommended a reliable change score and clinical cutoff 
score for the PCL-5, the recommendations were based on the PTSD criteria of the outdated 
DSM-IV-TR.  Further, no research was published documenting how the clinical cutoff score was 
calculated.  Due to the data gathered in the present study, clinicians now have the option of using 
a clinical cutoff score calculated using the Jacobson and Truax’s (1991) recommended method, 
which aids in determining whether clients’ scores fall within the clinical or non-clinical 
population.  The option of using a RCI to determine whether changes in PCL-5 scores are 
reliable is also a significant improvement for clinicians.  Clinicians now have the opportunity to 
determine whether the change in scores is a result of true change, which is helpful when utilizing 
self-report measures. 
Future Directions 
 This study contributed to the research on the PCL-5 in terms of developing a RCI to 
calculate a reliable change score and by collecting non-clinical normative data to utilize Cutoff C 
and calculate a clinical cutoff point.  The next step in this research is to replicate the study and 
address the aforementioned limitations to increase generalizability and to provide further insight 
into the results.  When replicating this study, it will be important to aim to gather data from a 
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larger total sample population with a larger clinical sample, as this will increase generalizability, 
decrease measurement error, and help determine whether results with a larger clinical sample 
would produce an alternative RCI or clinical cutoff score.  Further, it is recommended to use 
MTurk, as it is a reliable method for collecting survey data, and the snowball effect; however, it 
will be important to widen the recruitment area to include other geographic regions.  To address 
the limited insight into the effects of engaging in mental health treatment versus not engaging in 
mental health treatment on PCL-5 scores, it will be important to ask participants further follow-
up questions such as length of time between experiencing the traumatic event and taking the 
survey, whether mental health treatment was trauma focused, and whether participants in the 
non-clinical and non-trauma, non-clinical groups have ever engaged in mental health treatment.  
To address the potential confounding variable of co-occurring mental health issues, such 
as anxiety disorders, it will be important to ask participants if they have any mental health 
diagnoses.  This additional information would help determine the impact of other mental health 
disorders on the way participants answer the items on the PCL-5, especially participants who 
scored high on the PCL-5 but denied experiencing a traumatic event.  In order to gain further 
information on how PCL-5 scores are impacted by factors other than engaging in mental health 
treatment, it will be important to assess for protective factors such as positive social support, 
religious or spiritual beliefs, and community involvement. 
Conclusion 
Prior to conducting this research, non-clinical normative data was unavailable for the 
PCL-5.  As a result, clinicians were unable to utilize Cutoff C to calculate a clinical cutoff point 
and best assess whether their clients’ symptoms were more similar to the clinical or non-clinical 
population in terms of PTSD symptoms.  Further, the recommended change scores to determine 
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reliable change in scores were not developed using a RCI (Weathers et al., 2013).  Therefore, the 
purpose of this study was to collect data from a non-clinical population to aid in the process of 
determining a RCI and clinical cutoff score for the PCL-5, which in turn would help clinicians 
better determine whether changes in their clients’ PCL-5 scores are attributable to true change 
instead of measurement error; as well as help clinicians better determine whether their clients’ 
scores indicate movement towards a non-clinical population.  Results of this study produced both 
a RCI (RCI=12) and clinical cutoff score (C=27) and, despite the small sample sizes, these 
established recommendations for clinicians represent movement in the right direction to help 
clinicians provide the best evidence-based care to clients.   
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Appendix A 
Demographic Questionnaire 
1. How old are you? 
______________ 
2. What is your sex? 
- Male 
- Female 
- Other ____________ 
3. What is your race?  Choose all that apply: 
- White 
- Hispanic or Latino 
- Black or African American 
- Native American 
- Asian or Pacific Islander 
4. What is the highest degree or level of school you have completed?  If currently 
enrolled, choose the previous grade or highest degree received. 
- Nursery school to 8th grade 
- 9th, 10th, or 11th grade 
- 12th grade, no diploma 
- High School Diploma/GED 
- Some college credit, but less 
than 1 year 
- Associate degree (for 
example: AA, AS) 
- Bachelor’s degree (for 
example: BA, AB, BS) 
- Master’s degree (for 
example: MA, MS, MEng, 
Med, MSW, MBA) 
- 1 or more years of college, no 
degree 
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- Professional degree (for 
example: MD, DDS, DVM, 
LLB, JD) 
- Doctorate degree (for 
example: PhD, PsyD, EdD). 
5. What is your total household income? 
- Less than $10,000 
- $10,000 to $19,999 
- $20,000 to $29,999 
- $30,000 to $39,999 
- $40,000 to $49,999 
- $50,000 to $59,999 
- $60,000 to $69,999 
- $70,000 to $79,999 
- $80,000 to $89,999 
- $90,000 to $99,99 
-  $100,000 to $149,999 
- $150,000 or more 
6. Where do you live? 
- Outside the United States 
- United States 
o Which state do you live in? 
 Alabama 
 Alaska 
 Arizona 
 Arkansas 
 California 
 Colorado 
 Connecticut 
 Delaware 
 Florida 
 Georgia 
 Hawaii 
 Idaho 
 Illinois 
 Indiana 
 Iowa 
 Kansas 
 Kentucky 
 Louisiana 
 Maine 
 Maryland 
 Massachusetts 
 Michigan 
 Minnesota 
 Mississippi 
 Missouri 
 Montana 
 Nebraska 
 Nevada 
 New 
Hampshire 
 New Jersey 
 New Mexico 
 New York 
 North 
Carolina 
 North Dakota 
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 Ohio 
 Oklahoma 
 Oregon 
 Pennsylvania 
 Rhode Island 
 South 
Carolina 
 South Dakota 
 Tennessee 
 Texas 
 Utah 
 Vermont 
 Virginia 
 Washington 
 West Virginia 
 Wisconsin 
 Wyoming 
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Appendix B 
PCL-5 
In the past month, how much were you bothered by: Not 
at all 
A little 
bit 
Moderately Quite 
a bit 
Extremely 
1. Repeated, disturbing, and unwanted memories of the 
stressful experience? 
     
2. Repeated, disturbing dreams of the stressful experience?      
3. Suddenly feeling or acting as if the stressful experience 
were actually happening again (as if you were actually 
back there reliving it)? 
     
4. Feeling very upset when something reminded you of the 
stressful experience? 
     
5. Having strong physical reactions when something 
reminded you of the stressful experience (for example, 
heart pounding, trouble breathing, sweating)? 
     
6. Avoiding memories, thoughts, or feelings related to the 
stressful experience? 
     
7. Avoiding external reminders of the stressful experience 
(for example, people, places, conversations, activities, 
objects, or situations)? 
     
8. Trouble remembering important parts of the stressful 
experience? 
     
9. Having strong negative beliefs about yourself, other 
people, or the world (for example, having thoughts such as: 
I am bad, there is something seriously wrong with me, no 
one can be trusted, the world is completely dangerous)? 
     
10. Blaming yourself or someone else for the stressful 
experience or what happened after it? 
     
11. Having strong negative feelings such as fear, horror, 
anger, guilt, or shame? 
     
12. Loss of interest in activities that you used to enjoy?      
13. Feeling distant or cut off from other people?      
14. Trouble experiencing positive feelings (for example, 
being unable to feel happiness or have loving feelings for 
people close to you)? 
     
15. Irritable behavior, angry outbursts, or acting 
aggressively? 
     
16. Taking too many risks or doing things that could cause 
you harm? 
     
17. Being “super alert” or watchful or on guard?      
18. Feeling jumpy or easily startled?      
19. Having difficulty concentrating?      
20. Trouble falling or staying asleep?      
 
